Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

INTRODUCTION: Switching to a rilpivirine, tenofovir and emtricitabine (RTE) single-tablet regimen (STR) has been evaluated in a limited number of virologically suppressed patients. The aim of this study was to describe clinical outcomes in HIV-positive patients switched from a suppressive antiretrov...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianotti, Nicola, Poli, Andrea, Nozza, Silvia, Spagnuolo, Vincenzo, Tambussi, Giuseppe, Bossolasco, Simona, Cinque, Paola, Maillard, Myriam, Cernuschi, Massimo, Galli, Laura, Lazzarin, Adriano, Castagna, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522018/
https://www.ncbi.nlm.nih.gov/pubmed/26232000
http://dx.doi.org/10.7448/IAS.18.1.20037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522018/
https://www.ncbi.nlm.nih.gov/pubmed/26232000
http://dx.doi.org/10.7448/IAS.18.1.20037

Ejemplares similares